SCHEMBL9725988

SCHEMBL9725988

Cn1ccn(Cc2ccccc2)c1=S

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LPO P22079 3/20 0.62
ALDH1A1 P00352 3/20 0.49
DBH P09172 1/20 0.49
HDAC8 Q9BY41 2/20 0.47
HDAC6 Q9UBN7 2/20 0.47
KDM4E B2RXH2 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
NOTUM Q6P988 1/20 0.41
TP53 P04637 1/20 0.40
CYP2D6 P10635 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MC4R P32245 1/20 0.40
MMP2 P08253 1/20 0.40
MMP3 P08254 1/20 0.40
MMP9 P14780 1/20 0.40
MEN1 O00255 1/20 0.39
THRB P10828 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19411134 0.78 ALDH1A1 (0.46) LPOALDH1A1DBHHDAC8HDAC6
SCHEMBL15486314 0.77 ALDH1A1 (0.43) LPOALDH1A1DBHHDAC8HDAC6
SCHEMBL8301883 0.77 SMN1; SMN2 (0.47) ALDH1A1KDM4EL3MBTL1NOTUMTP53
SCHEMBL10978576 0.75 DBH (0.57) LPOALDH1A1DBHKDM4ESMN1; SMN2
SCHEMBL32676790 0.74 ALDH1A1 (0.41) LPOALDH1A1DBHHDAC8HDAC6
SCHEMBL32676540 0.73 ALDH1A1 (0.40) LPOALDH1A1DBHHDAC8HDAC6
SCHEMBL32676545 0.73 LPO (0.40) LPOALDH1A1DBHHDAC8HDAC6
SCHEMBL28490324 0.73 ALDH1A1 (0.45) LPOALDH1A1DBHHDAC8HDAC6
SCHEMBL15488252 0.70 MC4R (0.39) LPOALDH1A1DBHHDAC8HDAC6
SCHEMBL587606 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5098707-A Thioimidazolium salts as anticoagulants for platelet aggregation inhibitors MERCK & CO., INC. (US) 1992-03-24 US disclosed
US-5030644-A Thrombolytic, fibrinolytic therapy MERCK & CO., INC. (US) 1991-07-09 US disclosed
EP-0411705-A1 Imidazole compounds and their use as transglutaminase inhibitors MERCK & CO. INC. (US) 1991-02-06 EP disclosed